Laurus nobilis linn. Inhibits polyol pathway enzymes: Strategy for managing diabetic complications

Habeeb Adebodun Bankole, Azeez Ayomide Fatai, Sulihat Motunrayo Aleshe, Mutiu Idowu Kazeem, Abidemi Paul Kappo

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The rising incidence of diabetic complications necessitate the continuous search for safer, cheaper, and effective pharmacological agents. The polyol pathway is an underlying process implicated in the pathogenesis of diabetic complications. Inhibition of enzymes in the polyol pathway is a veritable means of ameliorating diabetic complications. Objective: This study evaluated the inhibitory potential of some spicy plants on the activities of polyol pathway enzymes (aldose reductase and sorbitol dehydrogenase). Methods: Aqueous extracts of Laurus nobilis (bay), Cinnamomum zeylanicum (cinnamon), Murraya koenigii (curry), Thymus vulgaris (thyme), and Curcuma longa (turmeric) were incubated with appropri-ate enzymes and substrates, and inhibition percentages were determined. Results: The results showed that bay extract had effective IC50 for the inhibition of both aldose reductase (174.87 µg/mL) and sorbitol dehydrogenase (37.08 µg/mL). It also revealed that bay extract inhibited aldose reductase and sorbitol dehydrogenase in a non-competitive and competitive manner, respectively. Conclusion: It is, therefore, concluded that bay extract effectively inhibited activities of polyol pathway enzymes and might contribute to the amelioration of diabetic complications.

Original languageEnglish
Pages (from-to)120-126
Number of pages7
JournalCurrent Enzyme Inhibition
Volume17
Issue number2
DOIs
Publication statusPublished - Jul 2021

Keywords

  • Aldose reductase
  • Bay
  • Diabetes mellitus
  • Phytochemicals
  • Sorbitol dehydrogenase
  • Spices

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Laurus nobilis linn. Inhibits polyol pathway enzymes: Strategy for managing diabetic complications'. Together they form a unique fingerprint.

Cite this